Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000006

Chief Executive Officer acquired 1,159 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hackman Jeffrey S. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-30 Exercise or conversion : show line 1 in the form +1,159 61,666 D
Loading xslF345X06/form4-05012026_040503.xml…